Literature DB >> 31600777

Nr2f1 heterozygous knockout mice recapitulate neurological phenotypes of Bosch-Boonstra-Schaaf optic atrophy syndrome and show impaired hippocampal synaptic plasticity.

Chun-An Chen1,2, Wei Wang1,2, Steen E Pedersen3,4,5, Ayush Raman2,6, Michelle L Seymour7, Fernanda R Ruiz7, Anping Xia7, Meike E van der Heijden2,8, Li Wang1,2, Jiani Yin1,2, Joanna Lopez1,2, Megan E Rech2, Richard A Lewis1,9, Samuel M Wu8,9, Zhandong Liu2,10, Fred A Pereira7, Robia G Pautler3,4, Huda Y Zoghbi1,2,10,11,12, Christian P Schaaf1,2,13.   

Abstract

Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) has been identified as an autosomal-dominant disorder characterized by a complex neurological phenotype, with high prevalence of intellectual disability and optic nerve atrophy/hypoplasia. The syndrome is caused by loss-of-function mutations in NR2F1, which encodes a highly conserved nuclear receptor that serves as a transcriptional regulator. Previous investigations to understand the protein's role in neurodevelopment have mostly used mouse models with constitutive and tissue-specific homozygous knockout of Nr2f1. In order to represent the human disease more accurately, which is caused by heterozygous NR2F1 mutations, we investigated a heterozygous knockout mouse model and found that this model recapitulates some of the neurological phenotypes of BBSOAS, including altered learning/memory, hearing defects, neonatal hypotonia and decreased hippocampal volume. The mice showed altered fear memory, and further electrophysiological investigation in hippocampal slices revealed significantly reduced long-term potentiation and long-term depression. These results suggest that a deficit or alteration in hippocampal synaptic plasticity may contribute to the intellectual disability frequently seen in BBSOAS. RNA-sequencing (RNA-Seq) analysis revealed significant differential gene expression in the adult Nr2f1+/- hippocampus, including the up-regulation of multiple matrix metalloproteases, which are known to be critical for the development and the plasticity of the nervous system. Taken together, our studies highlight the important role of Nr2f1 in neurodevelopment. The discovery of impaired hippocampal synaptic plasticity in the heterozygous mouse model sheds light on the pathophysiology of altered memory and cognitive function in BBSOAS.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31600777      PMCID: PMC7104670          DOI: 10.1093/hmg/ddz233

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD).

Authors:  Christian Lüscher; Robert C Malenka
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

2.  Hippocampal volume reduction in 22q11.2 deletion syndrome.

Authors:  Martin Debbané; Marie Schaer; Riaz Farhoumand; Bronwyn Glaser; Stephan Eliez
Journal:  Neuropsychologia       Date:  2006-06-19       Impact factor: 3.139

3.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

4.  Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites.

Authors:  Ezzat Hashemi; Peyman Sahbaie; M Frances Davies; J David Clark; Timothy M DeLorey
Journal:  Brain Res       Date:  2006-12-06       Impact factor: 3.252

5.  Hippocampal volume and depression: a meta-analysis of MRI studies.

Authors:  Poul Videbech; Barbara Ravnkilde
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

6.  NR2F1 mutations cause optic atrophy with intellectual disability.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Claudia Gonzaga-Jauregui; Mafei Xu; Joep de Ligt; Shalini Jhangiani; Wojciech Wiszniewski; Donna M Muzny; Helger G Yntema; Rolph Pfundt; Lisenka E L M Vissers; Liesbeth Spruijt; Ellen A W Blokland; Chun-An Chen; Richard A Lewis; Sophia Y Tsai; Richard A Gibbs; Ming-Jer Tsai; James R Lupski; Huda Y Zoghbi; Frans P M Cremers; Bert B A de Vries; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2014-01-23       Impact factor: 11.025

7.  Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins.

Authors:  K K Hsiao; D R Borchelt; K Olson; R Johannsdottir; C Kitt; W Yunis; S Xu; C Eckman; S Younkin; D Price
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

8.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

9.  Forniceal deep brain stimulation induces gene expression and splicing changes that promote neurogenesis and plasticity.

Authors:  Amy E Pohodich; Hari Yalamanchili; Ayush T Raman; Ying-Wooi Wan; Michael Gundry; Shuang Hao; Haijing Jin; Jianrong Tang; Zhandong Liu; Huda Y Zoghbi
Journal:  Elife       Date:  2018-03-23       Impact factor: 8.140

10.  Hippocampal volume reduction in children with chromosome 22q11.2 deletion syndrome is associated with cognitive impairment.

Authors:  Tracy Deboer; Zhongle Wu; Aaron Lee; Tony J Simon
Journal:  Behav Brain Funct       Date:  2007-10-23       Impact factor: 3.759

View more
  2 in total

Review 1.  Pathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome.

Authors:  Michele Bertacchi; Chiara Tocco; Christian P Schaaf; Michèle Studer
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

Review 2.  Structural and Functional Aspects of the Neurodevelopmental Gene NR2F1: From Animal Models to Human Pathology.

Authors:  Chiara Tocco; Michele Bertacchi; Michèle Studer
Journal:  Front Mol Neurosci       Date:  2021-12-15       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.